Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-183-6 | CAS number: 16040-69-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
A category assessment is performed, which is based on the hypothesis that the copper phthalocyanine pigments are too insoluble in water or fat / octanol for systemic uptake. A data matrix and further information are provided in the chapter on toxicokinetic properties. The pigment is considered to show no adverse effects at the limit dose for the oral and dermal route. It is considered to behave like an inert dust upon inhalation.
Data on category members is summarized below:
CAS No. 147-14-8: A GLP conform reproduction/developmental toxicity screening study was conducted by gavage with the test material according to OECD guideline 421 (JETOC 1995). Groups of 12 Sprague-Dawley per sex per dose were daily exposed by gavage to 0, 40, 200, 1000 mg/kg bw/day of the test substance. The administration period for males was from 14 days before mating, during the mating period and copulation, until 46 days. The administration period for females was from 14 days before mating to day 3 of lactation. Males were killed on days 28 and 47, females on day 28 and on day 4 of lactation. Maternal examinations included cage side observations (at least once every day visual inspection, observation of appearance and palpation), detailled clinical observations (reproductive capacity, examination of the oestrous cycle, the recording of occurrence of copulation and gestation, fertility, implantation, delivery and nursing indices, maternal behaviour, birth rate, pregnancy period), examination of body weight and of feed intake. Post-mortem examinations were conducted: Organs were removed, reproductive organs were weighed. Ovaries, uterus, harderian gland, eyeball, mammary gland, and spleen were histopathologically examined. The ovaries and uterine content were examined after termination. The examinations included gravid uterus weight, number of corpora lutea and the number of implantations. Fetal examinations were also conducted, details are listed below.A blue coloration of faeces was noted in all animals of the groups receiving 40 mg/kg bw or more; moreover blue-green or grayish blue discolorations of the contents of the stomach and intestines were noted in a few animals of the 200 mg/kg group and in almost all animals of both sexes in the 1000 mg/kg group. These changes were due to the colour of the test substance. No changes were observed in terms of mortality, body weight, food consumption, organ weight and histopathological examination. No effects were noted on the following endpoints: Reproductive ability of either sex (assessment of this endpoint included the examination of the oestrous cycle, the recording of occurrence of copulation and gestation, the calculation of copulation, fertility, implantation, delivery and nursing indices, the weight of testes and epididymis as well as histopathological examination of the reproductive organs), delivery, maternal behavior, viability, clinical signs and body weight changes. No statistically significant differences were observed in rate of live/dead pups born. CAS No. 1328 -53 -6: Additionally, repeated dose toxicity studies with polychloro copper phthalocyanine and copper phthalocyanine (for study details see chapter 7.5) reported no changes in rats' testes (90-day and 28-day study) and ovaries (28-day study) as confirmed by histopathological investigations.Short description of key information:
The copper phthalocyanine pigments are considered to be too insoluble and bulky for systemic uptake. A screening study (OECD 421) with the smallest copper phthalocyanine showed no effects at the limit dose. Also, no effects on reproductive organs were noted upon subchronic feeding of mice and rats. Overall, the substance is considered to be non toxic to reproduction.
Effects on developmental toxicity
Description of key information
Fertility / Developmental Toxicity:
Screening test, rat, oral by gavage: NOAEL P/F1 = 1000 mg/kg bw/day (acc. OECD guideline 421, GLP, JETOC 1995)
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- subacute
- Species:
- rat
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
A category assessment is performed, which is based on the hypothesis that the copper phthalocyanine pigments are too insoluble in water or fat / octanol for systemic uptake. A data matrix and further information are provided in the chapter on toxicokinetic properties. The pigment is considered to show no adverse effects at the limit dose for the oral and dermal route. It is considered to behave like an inert dust upon inhalation.
Data on category members is summarized below:
CAS No. 147-14-8:
A GLP conform reproduction/developmental toxicity screening study was conducted by gavage with the test material according to OECD guideline 421 (JETOC 1995). Groups of 12 Sprague-Dawley per sex per dose were daily exposed by gavage to 0 40, 200, 1000 mg/kg bw/day of the test substance. The administration period for males was from 14 days before mating, during the mating period and copulation, until 46 days. The administration period for females was from 14 days before mating to day 3 of lactation. Males were killed on days 28 and 47, females on day 28 and on day 4 of lactation. Maternal examinations were conducted, details are listed above. Fetal examinations included general observations about the state (clinical signs, body weight change) and neonatal survival status. Post-mortem, the whole body was fixed in formalin solution.
No statistically significant differences were observed in rate of live/dead pups born. No evidence was found suggesting a relation with the administration of the tested substance and clinical signs, body weight change or autopsy findings for both male and female pups.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available screening study is considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for fertility or developmental toxicity under Directive 67/548/EEC, as amended for the 31st time in Directive2009/2/EG.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available screening study is reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for fertility or developmental toxicity under Regulation (EC) No. 1272/2008, as amended for the fifth time in Directive EC944/2013.
During the four days covered in the screening study, no effects via lactation were observed.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.